Septic shock, multiple organ failure, and acute respiratory distress syndrome

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pathophysiology

Background:

• Sepsis involves microbial invasion and an exaggerated host inflammatory response, leading to septic shock and multiorgan failure.
• Sepsis, severe sepsis, and septic shock represent a continuum of clinical syndromes characterized by inflammation, coagulopathy, and hemodynamic instability.
• Despite advances, sepsis and septic shock remain leading causes of mortality in the US, with death rates comparable to myocardial infarction.

Purpose of the Study:

• To review recent advances in understanding the pathophysiology of sepsis.
• To discuss novel management strategies for sepsis, particularly focusing on the coagulation cascade.

Main Methods:

• This review synthesizes current scientific literature on sepsis pathophysiology and treatment.
• It highlights recent findings on inflammatory mediators and coagulation abnormalities in sepsis.
• The review discusses the clinical implications of modulating the coagulation cascade.

Main Results:

• Inflammatory mediators are central to the pathogenesis of septic shock and multiorgan failure.
• Modulating the coagulation cascade has emerged as a promising strategy to reduce sepsis mortality.
• Despite past disappointments with anti-inflammatory approaches, coagulation-focused therapies show clinical promise.

Conclusions:

• Sepsis pathophysiology is complex, involving systemic inflammation and coagulopathy.
• Targeting the coagulation cascade represents a significant advancement in sepsis management.
• Further research and clinical application of coagulation modulation strategies are crucial for reducing sepsis mortality.